Skip to main content

Cigna Group

For the period ended Mar 31, 2025. Filed May 2, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 2, 2025

CI$303.13+2.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Income

The Cigna GroupConsolidated Statements of Income
Unaudited
Three Months Ended March 31,
(In millions, except per share amounts)20252024
Revenues
Pharmacy revenues$48,633$42,036
Premiums12,73611,603
Fees and other revenues3,8953,326
Net investment income238290
TOTAL REVENUES65,50257,255
Benefits and expenses
Pharmacy and other service costs48,39841,431
Medical costs and other benefit expenses10,4989,440
Selling, general and administrative expenses4,2133,705
Amortization of acquired intangible assets422423
TOTAL BENEFITS AND EXPENSES63,53154,999
Income from operations1,9712,256
Interest expense and other(362)(322)
Gain (loss) on sale of businesses41(19)
Net investment losses(2)(1,836)
Income before income taxes1,64879
TOTAL INCOME TAXES239291
Net income (loss)1,409(212)
Less: Net income attributable to noncontrolling interests8665
SHAREHOLDERS' NET INCOME (LOSS)$1,323$(277)
Shareholders' net income (loss) per share
Basic$4.88$(0.97)
Diluted$4.85$(0.97)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.